To ensure that the drug or physiological saline solution reaches the site of action, it is nebulised into tiny droplets: the aerosol.
The substances can then be directly absorbed via the mucous membranes of the upper or lower airways. Where they actually arrive and how they work depends on factors such as their physical size.
The larger droplets are already absorbed within the upper airways: in the mouth or throat, the larynx or the nose, depending on the inhalation technique used.
Smaller droplets on the other hand are able to reach the lower airways.
For targeted treatment of the lower airways it is important to use a droplet spectrum which is suited to the age group of the patient and the required target area in the body. In children and infants for example, the airways are not as wide and call for a finer droplet spectrum than the airways tract of adults.
Some drugs should ideally be directed to the peripheral areas of the lung, while others need to be deposited centrally.
The PARI LC SPRINT Nebulisers are equipped with various nozzle inserts designed to produce different droplet spectrums and represents a solution that caters to the individual needs of patients.
To supply the upper airways (pharynx, larynx and trachea) with drugs at the best, particularly large aerosol droplets are needed. The transparent insert of the PARI LC SPRINT Xlent nebuliser generates these XL-droplets, that provides an ideal aerosol spectrum e.g. for the treatment of Croup, Laryngitis and Pharyngitis.
Tiny droplets for the peripheral area of the lung, or for babies (premature infants upwards).
Included in the PARI LC SPRINT BABY Nebuliser and the PARI LC SPRINT STAR Nebuliser and the PARI BOY SX set (in addition to the blue insert). Designed specifically with COPD in mind to reach the finest structures of the lung.